VitriVax, Inc.

SEC filing

Biotechnology · Boulder, CO

Form D on EDGAR

Amount raised$29.4Msold at filing

Total offering$37.1M$7.7M still open

Investors in the raise83count reported to the SEC

FiledNov 17, 2025first sale Jun 30, 2025

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Glenn RockmanDirector

Rene LorenzDirector

Louise BradyDirector

Theodore RandolphDirector

Romulo ColindresExecutive Officer, Director, Promoter

Executive officers, directors and promoters as listed on the Form D.